Andrew Saxon, MD
Personal Statement
My area of expertise is addiction psychiatry.
Department Affiliations
Centers/Programs
Training Programs
Scholarly Expertise
Teaching Philosophy
My training philosophy involves serving as a role model for my trainees as well as generally apply a supportive, Socratic method.
- NIDA Clinical Trials Network: Pacific Northwest Node
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Impact of medical and recreational marijuana laws on cannabis, opioids and psychiatric medications: national study of VA patients, 2000 – 2024
- Preventing addiction related suicide
- Evaluating the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) Program
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Association between state cannabis laws and opioid outcomes: A systematic review.
(2026 Apr 17)
Drug Alcohol Depend 284(): 113167
Fink DS, Gorfinkel L, Gutkind S, Bachowski D, Mannes ZL, Livne O, Malte C, Bruzelius E, Olfson M, Martins SS, Cerdá M, Keyhani S, Saxon AJ, Wall M, Hasin DS
(2026 Apr 17)
Drug Alcohol Depend 284(): 113167
Fink DS, Gorfinkel L, Gutkind S, Bachowski D, Mannes ZL, Livne O, Malte C, Bruzelius E, Olfson M, Martins SS, Cerdá M, Keyhani S, Saxon AJ, Wall M, Hasin DS
Implementing pragmatic clinical trials in rural settings: Challenges, solutions and lessons learned.
(2026 Apr 23)
J Subst Use Addict Treat
Hser YI, Ober AJ, Baldwin LM, Lin C, Saxon AJ, McLeman B, Marsch LA, Holzer C, Mooney LJ
(2026 Apr 23)
J Subst Use Addict Treat
Hser YI, Ober AJ, Baldwin LM, Lin C, Saxon AJ, McLeman B, Marsch LA, Holzer C, Mooney LJ
Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and design.
(2026 May)
Contemp Clin Trials 164(): 108288
Mooney LJ, Saxon AJ, Black M, Ober AJ, Lewis M, Walker R, McCormack J, Scheele C, Hser YI
(2026 May)
Contemp Clin Trials 164(): 108288
Mooney LJ, Saxon AJ, Black M, Ober AJ, Lewis M, Walker R, McCormack J, Scheele C, Hser YI
Smartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives.
(2026 Feb 19)
JMIR Form Res 10(): e80808
Chang YM, Ketron AC, Duncan MH, Iles-Shih MD, Saxon AJ, Hallgren KA
(2026 Feb 19)
JMIR Form Res 10(): e80808
Chang YM, Ketron AC, Duncan MH, Iles-Shih MD, Saxon AJ, Hallgren KA
Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings.
(2026 Apr)
J Subst Use Addict Treat 183(): 209895
Livingston NR, Malte CA, Frost MC, Saxon AJ, Gordon AJ, Hagedorn HJ, Kennedy AJ, Williams EC, Hawkins EJ
(2026 Apr)
J Subst Use Addict Treat 183(): 209895
Livingston NR, Malte CA, Frost MC, Saxon AJ, Gordon AJ, Hagedorn HJ, Kennedy AJ, Williams EC, Hawkins EJ
Show complete publication list »
